Grant: Collaborative Health Research Projects
McMaster University
$112,734.00
Overcoming antibiotic resistance through the inhibition of aminoglycoside phosphotransferases (APH).
FY 2014-15
Summary
Multidrug resistant microbes have become one of the top global health challenges and place a massive burden on theCanadian health care system. One approach to overcome this problem involves inhibiting the enzymes responsible forconferring resistance to the antibiotic. We have recently discovered a family of compounds that blocks the action of a seriesof aminoglycoside phosphotransferases (APH) and wish to develop the compounds to ultimately provide an optimized, ontarget, on-mechanism lead suitable for development into a therapeutic agent.
Program
Collaborative Health Research Projects
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
446433-2013
Name nom
Capretta, Alfredo
Department département
Chemistry & Chemical Biology
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2013
Award amount
112734
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
2 & 3
Nb partie
3
Application title
Overcoming antibiotic resistance through the inhibition of aminoglycoside phosphotransferases (APH).
Keyword
NSERC
Application summary
Multidrug resistant microbes have become one of the top global health challenges and place a massive burden on theCanadian health care system. One approach to overcome this problem involves inhibiting the enzymes responsible forconferring resistance to the antibiotic. We have recently discovered a family of compounds that blocks the action of a seriesof aminoglycoside phosphotransferases (APH) and wish to develop the compounds to ultimately provide an optimized, ontarget, on-mechanism lead suitable for development into a therapeutic agent.